Skip to main content
Clinical Trials/NCT05477433
NCT05477433
Not yet recruiting
Not Applicable

Psychiatric Disorders Related to Diabetes Mellitus Type 1 Among Adolescents in Egypt

Assiut University0 sites140 target enrollmentAugust 1, 2022

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Diabetes Mellitus Type 1
Sponsor
Assiut University
Enrollment
140
Primary Endpoint
Measure frequency of sleep problems with diabetes mellitus type 1
Status
Not yet recruiting
Last Updated
3 years ago

Overview

Brief Summary

The most common endocrine illness in children and adolescents is type 1 diabetes. It is distinguished by a lack of insulin synthesis and necessitates daily insulin injections to keep glucose levels under control. As a result, there are numerous medical approaches to its management, such as levels of glycosylated haemoglobin (HbA1c) as a marker of glycemic control during the previous three months and monitoring of blood glucose levels, which affect the patient's mental health and quality of life. Type 1 diabetes complications and poor quality of life are widespread. Diabetes therapy is difficult during puberty and adolescence. Adolescents with T1D have poor metabolic control and a higher rate of acute complications. Because the onset of adolescence is frequently associated with decreased adherence to therapy and an increased risk of psychological illnesses.

Registry
clinicaltrials.gov
Start Date
August 1, 2022
End Date
December 1, 2025
Last Updated
3 years ago
Study Type
Observational
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Gellan Karamalllah Ramadan Ahmed

lecturer of neurology and psychiatry,faculty of medicine

Assiut University

Eligibility Criteria

Inclusion Criteria

  • Both males and females were included.
  • Age ranges from 10 to 19 years.
  • Willing of the parents or the caregivers to participate in the study.
  • Duration of T1DM of at least 1 year.
  • Exclusion Criteria
  • Adolescents with an intelligence quotient below
  • Adolescents with a history of substance use or psychiatric disorders.
  • Adolescents with medical or other neurological conditions.

Exclusion Criteria

  • Not provided

Outcomes

Primary Outcomes

Measure frequency of sleep problems with diabetes mellitus type 1

Time Frame: through study completion, an average of 1 year

Measures frequency of psychiatric problems with diabetes mellitus type 1

Time Frame: through study completion, an average of 1 year

Similar Trials